#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous calcification Acromegaly Erythema multiforme Amyloidosis Astrocytoma malignant Biliary cancer metastatic Anti-myelin-associated glycoprotein antibodies positive Immune-mediated myasthenia gravis Interstitial lung disease Colitis ulcerative Chemical burn Osteosarcoma recurrent Chronic lymphocytic leukaemia Basal cell naevus syndrome Fibrosarcoma More trials…

    Learn about Rare Diseases

    Krabbe’s disease – Treatment Rhabdomyosarcoma recurrent – Basic Information Lymphatic malformation – Basic Information Hereditary ataxia Angelman’s syndrome – Trials in Disease Fabry’s disease – Diagnostics Mantle cell lymphoma stage III – Basic Information Pulmonary sarcoidosis Fragile X syndrome – Trials in Disease Osteosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSK5764227 INF904 Tramazoline Hydrochloride JX10 Oteracil Xxb750 Relacorilant Oric-114 Entecavir LUNRESERTIB Bimatoprost Abacavir Sertraline Hydrochloride Arginine Apg777 Icatibant Betula Verrucosa Pollen Buprenorphine CARBOMER 980 SUMATRIPTAN More therapies…

    Learn about Your Condition

    Aneurysm ruptured Diabetic gastroparesis Urticaria cholinergic Anaemia of pregnancy Pulmonary venous thrombosis Bacteraemia Ischaemic stroke Viral infection Renal failure HER2 protein overexpression Colon cancer stage IV Glucose tolerance impaired Oesophageal food impaction Hypertrophic scar Follicular thyroid cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Maintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer

    Recruiting

    3 1 1
    Investigated Drugs:
    • Tamoxifen
    • Anastrozole
    • Goserelin Acetate
    Belgium Finland France Germany Italy Poland +1

  • Efficacy and safety of gadopiclenol versus gadoteric acid‑enhanced MRA in adult patients with suspected vascular disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Gadoteric Acid
    Czechia France Germany Hungary Italy Poland +1

  • Study of glofitamab, obinutuzumab and tocilizumab in patients with mantle cell lymphoma relapsed or refractory after CAR‑T therapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Glofitamab
    • Obinutuzumab
    • Tocilizumab
    Italy

  • Phase 1/2A Study of OTP-01 to Evaluate Safety and Anti‑Tumor Activity in Patients with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    • Neoplasm malignant
    Ireland Portugal Spain

  • Phase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury

    Recruiting

    2 1 1
    Investigated Diseases:
    • Craniocerebral injury
    Investigated Drugs:
    • Cenegermin
    Denmark Finland France Germany Italy Poland +2

  • Randomized trial of bupropion hydrochloride for fatigue in patients with long COVID (post‑COVID syndrome)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Bupropion Hydrochloride
    Germany
Previous Page
1 … 30 31 32 33 34 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!